SPOTLIGHT -
When determining whether a diagnosis of attention-deficit/hyperactivity disorder (ADHD) is the correct diagnosis, here are 5 important criteria to consider.
TNX-2900 to treat Prader-Willi syndrome granted Rare Pediatric Disease designation
TNX-2900 was previously granted Orphan Drug designation by the federal agency in 2022 for the treatment of PWS.
Food Insecurity and the Dangers of Infant Formula Dilution
CDC: More measles cases reported in 2024 than all of 2023
As of March 21, 2024, 64 measles cases have been reported to the CDC by 17 jurisdictions.
Demystifying Infant Formula
FDA approves givinostat for Duchenne muscular dystrophy in patients 6 years and up
The decision makes givinostat the first nonsteroidal drug approved to treat patients with all genetic variants of DMD.
Screening for perinatal mental health disorders
Cynthia Chew, DNP, CPNP-PC, IBCLC, assistant professor, University of Pittsburgh, breaks down her session, "The Why and How of Screening for Perinatal Mental Health Disorders in Pediatric Primary Care," presented at NAPNAP 2024.